These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20479414)

  • 1. Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma.
    Lagro J; Melis RJ; Olde Rikkert MG
    J Clin Oncol; 2010 Jun; 28(18):e298; author reply e301. PubMed ID: 20479414
    [No Abstract]   [Full Text] [Related]  

  • 2. Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma.
    Lughezzani G; Sun M; Budäus L; Thuret R; Perrotte P; Karakiewicz PI
    J Clin Oncol; 2010 Jun; 28(18):e299-300; author reply e301. PubMed ID: 20479402
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
    Kutikov A; Egleston BL; Wong YN; Uzzo RG
    J Clin Oncol; 2010 Jan; 28(2):311-7. PubMed ID: 19933918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension.
    Gettman MT; Boelter CW; Cheville JC; Zincke H; Bryant SC; Blute ML
    J Urol; 2003 Apr; 169(4):1282-6. PubMed ID: 12629343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Remzi M
    Eur Urol; 2009 Jun; 55(6):1427-8. PubMed ID: 19147268
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Volpe A
    Eur Urol; 2009 Jun; 55(6):1428-9. PubMed ID: 19147272
    [No Abstract]   [Full Text] [Related]  

  • 13. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
    Billis A
    Int Braz J Urol; 2004; 30(4):347-8. PubMed ID: 15679982
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
    Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
    J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathology of benign and malignant renal cell tumors].
    Thoenes W; Störkel S
    Urologe A; 1991 Nov; 30(6):W41-50. PubMed ID: 1771712
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.
    Cheville JC; Frank I; Leibovich BC; Lohse CM; Blute ML
    J Urol; 2004 Sep; 172(3):1196; author reply 1196. PubMed ID: 15311069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.